Lv2
116 积分 2022-04-23 加入
Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets
2天前
已完结
Ruxolitinib versus basiliximab for steroid-refractory acute graft-versus-host disease: a retrospective study
3个月前
已完结
Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody—Begelomab
6个月前
已完结
Ruxolitinib versus basiliximab for steroid-refractory acute graft-versus-host disease: a retrospective study
6个月前
已完结
Optimal two-stage designs for phase II clinical trials
7个月前
已完结
Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial
8个月前
已完结
Novel Janus-kinase (JAK) Inhibitors in Myelofibrosis
8个月前
已完结
IDH2 and NPM1 Mutations Cooperate to Activate Hoxa9/Meis1 and Hypoxia Pathways in Acute Myeloid Leukemia
10个月前
已完结
A First-in-Class JAK/ROCK Inhibitor, Rovadicitinib, for Glucocorticoid-Refractory or -Dependent Chronic GVHD
1年前
已完结
Coinfusion of Mesenchymal Stromal Cells Facilitates Platelet Recovery Without Increasing Leukemia Recurrence in Haploidentical Hematopoietic Stem Cell Transplantation: A Randomized, Controlled Clinical Study
1年前
已完结
皖公网安备34019202002308
